Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials

A. Blauvelt; K. Reich; K.A. Papp; A.B. Kimball; M. Gooderham; S.K. Tyring; R. Sinclair; D. Thaçi; Q. Li; N. Cichanowitz; S. Green; C. La Rosa

doi:10.1111/bjd.16724

Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials

British Journal of Dermatology ◽

10.1111/bjd.16724 ◽

2018 ◽

Vol 179 (3) ◽

pp. 615-622 ◽

Cited By ~ 21

Author(s):

A. Blauvelt ◽

K. Reich ◽

K.A. Papp ◽

A.B. Kimball ◽

M. Gooderham ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Pooled Analysis ◽

Controlled Trials ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.15400 ◽

2019 ◽

Vol 33 (6) ◽

pp. 1098-1106 ◽

Cited By ~ 7

Author(s):

K.A. Papp ◽

K. Reich ◽

A. Blauvelt ◽

A.B. Kimball ◽

M. Gooderham ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Pooled Analysis ◽

Controlled Trials ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Faculty Opinions recommendation of Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718010200.793476613 ◽

2013 ◽

Author(s):

Victoria Werth

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Global Assessment ◽

Severity Index ◽

Biologic Agents ◽

Controlled Trials ◽

Physician Global Assessment ◽

Systematic Analysis ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Certolizumab pegol for the treatment of patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.15258 ◽

2018 ◽

Vol 33 (3) ◽

pp. 546-552 ◽

Cited By ~ 9

Author(s):

A. Blauvelt ◽

K. Reich ◽

M. Lebwohl ◽

D. Burge ◽

C. Arendt ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Certolizumab Pegol ◽

Pooled Analysis ◽

Controlled Trials ◽

Chronic Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials

International Immunopharmacology ◽

10.1016/j.intimp.2018.06.020 ◽

2018 ◽

Vol 62 ◽

pp. 46-58 ◽

Cited By ~ 23

Author(s):

Lian Cui ◽

Rongfen Chen ◽

Smriti Subedi ◽

Qian Yu ◽

Yu Gong ◽

...

Keyword(s):

Systematic Review ◽

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.12238 ◽

2013 ◽

Vol 28 (12) ◽

pp. 1633-1653 ◽

Cited By ~ 50

Author(s):

L. Puig ◽

A. López ◽

E. Vilarrasa ◽

I. García

Keyword(s):

Systematic Review ◽

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Meta Analysis ◽

Controlled Trials ◽

Severe Plaque Psoriasis ◽

Time Points ◽

Randomized Controlled

Download Full-text

Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.03.040 ◽

2018 ◽

Vol 79 (2) ◽

pp. 287-293 ◽

Cited By ~ 15

Author(s):

Linda Stein Gold ◽

Mark G. Lebwohl ◽

Jeffrey L. Sugarman ◽

David M. Pariser ◽

Tina Lin ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Fixed Combination ◽

Controlled Trials ◽

Phase 3 ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials

British Journal of Dermatology ◽

10.1111/j.1365-2133.2008.08673.x ◽

2008 ◽

Vol 159 (2) ◽

pp. 274-285 ◽

Cited By ~ 99

Author(s):

A.K. Brimhall ◽

L.N. King ◽

J.C. Licciardone ◽

H. Jacobe ◽

A. Menter

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Meta Analysis ◽

Controlled Trials ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Immunogenicity with tildrakizumab, an anti–IL-23p19 monoclonal antibody, in a pooled analysis of three randomized controlled trials in patients with chronic plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.648 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB157

Keyword(s):

Monoclonal Antibody ◽

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Pooled Analysis ◽

Controlled Trials ◽

Chronic Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Corrigendum to “Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials” [Int. Immunopharmacol. 62 (2018) 46–58]

International Immunopharmacology ◽

10.1016/j.intimp.2018.08.039 ◽

2018 ◽

Vol 64 ◽

pp. 432

Author(s):

Lian Cui ◽

Rongfen Chen ◽

Smriti Subedi ◽

Qian Yu ◽

Yu Gong ◽

...

Keyword(s):

Systematic Review ◽

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text

Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2012.05.047 ◽

2013 ◽

Vol 68 (6) ◽

pp. 1040-1041 ◽

Cited By ~ 2

Author(s):

Alexander Nast ◽

Jochen Schmitt

Keyword(s):

Randomized Controlled Trials ◽

Plaque Psoriasis ◽

Global Assessment ◽

Severity Index ◽

Biologic Agents ◽

Controlled Trials ◽

Physician Global Assessment ◽

Systematic Analysis ◽

Severe Plaque Psoriasis ◽

Randomized Controlled

Download Full-text